Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market to Reach USD 17.19 Billion by 2030 Amid Rising Demand for Minimally Invasive Procedures
The global benign prostatic hyperplasia (BPH) surgical treatment market is experiencing steady growth, driven by the increasing prevalence of prostate enlargement among aging men, advancements in minimally invasive treatment technologies, and rising awareness of effective BPH management. Valued at USD 11.92 billion in 2023, the market reached USD 12.62 billion in 2024 and is projected to grow...
0 Commentaires 0 Parts 71 Vue 0 Aperçu
Commandité